Summary
Bill & Melinda Gates Foundation (BMGF), formerly William H. Gates Foundation is a healthcare service foundation that provides health development programs. The foundation concentrates on improving healthcare, decrease poverty in America and provides access to information equipment. It offers global health services in the fields of discovery and translational sciences, enteric and diarrheal diseases, HIV, malaria, neglected infectious diseases, and tuberculosis services. BMGF’s global development services include agricultural development, family planning, emergency response, financial services for the poor, nutrition fulfillment, vaccine delivery, and water, sanitation and hygiene services. The foundation has its presence in Asia, Africa, Europe, North America, South America, and Oceania. BMGF is headquartered in Seattle, Washington, the US.
Bill & Melinda Gates Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bill & Melinda Gates Foundation, Medical Devices Deals, 2011 to YTD 2017 9
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Kymab Raises USD100.5 Million in Series C Financing 13
Just Biotherapeutics Raises USD14 Million in Series A2 Financing 14
Affinivax Raises USD2.5 Million in Venture Financing 15
Lodo Therapeutics Raises USD17 Million in Series A Financing 16
Atreca Raises USD56 Million in Series A Financing 18
CureVac to Raise USD76 Million in Venture Financing 19
Affinivax Raises USD4 Million in Seed Venture Financing 20
Synlogic Raises Additional USD5 Million in Series A Venture Financing 21
Kymab Raises USD40 Million in Series B Financing 22
Visterra Raises US$8.1 Million In Extended Series A Financing 23
Visterra Raises Additional US$13 Million In Series A Financing 25
Genocea Biosciences Raises US$30 Million In Series C Financing 26
Partnerships 29
CureVac to Enter into Development Agreement with Bill & Melinda Gates 29
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 30
GSK Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 31
Anacor Pharma Enters Into Research Agreement With Bill & Melinda Gates Foundation 32
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 33
Equity Offering 34
Intarcia Therapeutics Raises USD206 Million in Second Tranche of Private Placement of Shares 34
CureVac Raises USD110 Million in Private Placement of Shares 35
Bill & Melinda Gates Foundation - Key Competitors 37
Key Employees 38
Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Tables
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Key Facts 1
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bill & Melinda Gates Foundation, Deals By Therapy Area, 2011 to YTD 2017 8
Bill & Melinda Gates Foundation, Medical Devices Deals, 2011 to YTD 2017 9
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Kymab Raises USD100.5 Million in Series C Financing 13
Just Biotherapeutics Raises USD14 Million in Series A2 Financing 14
Affinivax Raises USD2.5 Million in Venture Financing 15
Lodo Therapeutics Raises USD17 Million in Series A Financing 16
Atreca Raises USD56 Million in Series A Financing 18
CureVac to Raise USD76 Million in Venture Financing 19
Affinivax Raises USD4 Million in Seed Venture Financing 20
Synlogic Raises Additional USD5 Million in Series A Venture Financing 21
Kymab Raises USD40 Million in Series B Financing 22
Visterra Raises US$8.1 Million In Extended Series A Financing 23
Visterra Raises Additional US$13 Million In Series A Financing 25
Genocea Biosciences Raises US$30 Million In Series C Financing 26
CureVac to Enter into Development Agreement with Bill & Melinda Gates 29
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 30
GSK Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 31
Anacor Pharma Enters Into Research Agreement With Bill & Melinda Gates Foundation 32
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 33
Intarcia Therapeutics Raises USD206 Million in Second Tranche of Private Placement of Shares 34
CureVac Raises USD110 Million in Private Placement of Shares 35
Bill & Melinda Gates Foundation, Key Competitors 37
Bill & Melinda Gates Foundation, Key Employees 38
Bill & Melinda Gates Foundation, Other Locations 39
List of Figures
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bill & Melinda Gates Foundation, Medical Devices Deals, 2011 to YTD 2017 9
